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Lin28a inhibits the biogenesis of let-7 miRNAs by triggering the polyuridylation and 
degradation of their precursors by terminal uridylyltransferases TUT4/7 and 3’-5’ 
exoribonuclease Dis3l2, respectively. Previously, we showed that Lin28a also 
controls the production of neuro-specific miRNA-9 via a polyuridylation-independent 
mechanism. Here we reveal that the sequences and structural characteristics of pre-let-
7 and pre-miRNA-9 are eliciting two distinct modes of binding to Lin28a. We present 
evidence that Dis3l2 controls miRNA-9 production. Finally, we show that the 
constitutive expression of untagged Lin28a during neuronal differentiation in vitro 
positively and negatively affects numerous other miRNAs. Our findings shed light on 
the role of Lin28a in differentiating cells and on the ways in which one RNA-binding 
protein can perform multiple roles in the regulation of RNA processing. 
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INTRODUCTION 
Cell lineage abnormal 28a (Lin28a) is one of the best-studied proteins with respect to 
its role in the regulation of miRNA biogenesis. Lin28a is very well conserved across 
many species, and it was first described in C. elegans, in which mutations of the 
protein cause defects in developmental timing and accelerate the differentiation of 
several types of cells (Moss et al. 1997). It contains two highly conserved RNA-
binding motifs forming cold-shock (CSD) and tandem zinc-finger (ZnF) domains, 
with 79–90% homology at the amino acid level across vertebrates  (Ouchi et al. 2014). 
These domains are present in a number of RNA-binding proteins (such as YBX2, 
FRGY2 or NCp7) however Lin28 proteins are the only metazoan proteins to have 
both (Balzer and Moss 2007). Expression profiling in metazoans showed that Lin28a 
is abundantly expressed in the early stages of embryonic development, during which 
it inhibits the biogenesis of miRNAs from the let-7 family. Lin28a expression is 
gradually restricted with lineage progression, which allows de-repression of let-7 
production in more developed and differentiated cells (Seggerson et al. 2002; Moss 
and Tang 2003; Darr and Benvenisty 2009; Van Wynsberghe et al. 2011). The main 
mechanism by which Lin28a inhibits let-7 biogenesis is based on its interaction with 
the conserved terminal loop (CTL) (Michlewski et al. 2008) of pre-let-7 (Wulczyn et 
al. 2007; Newman et al. 2008; Rybak et al. 2008). This event creates a platform for 
terminal uridylyltransferase 4 (TUT4) and other members from the TUT family, 
which catalyze the addition of a poly(U) tail to pre-let-7 (Hagan et al. 2009; Thornton 
et al. 2012). Poly-uridylation ultimately results in pre-let-7 destabilization and a 
decrease of mature let-7 (Hagan et al. 2009; Heo et al. 2009). The degradation of 
poly(U) pre-let-7 is performed in the cytoplasm independently of the RNA exosome 
by 3’-5’ Dis3l2 exoribonuclease from the RNase II/RNB family (Chang et al. 2013; 
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Ustianenko et al. 2013), which has a preference for unstructured and poly-U-rich 
RNAs (Chang et al. 2013; Malecki et al. 2013; Munoz-Tello et al. 2015; Viegas et al. 
2015). Moreover, polyuridylation of pre-let-7 precludes Dicer from generating mature 
let-7 (Heo et al. 2009). Other mechanisms for the control of let-7a that operate at the 
level of DGCR8/Drosha processing have also been suggested (Piskounova et al. 2008). 
Additionally, close homologue Lin28b also controls let-7 levels in vivo (Shyh-Chang 
and Daley 2013; Golden et al. 2015). 
 
Recently, we have shown that during the early stages of neuronal differentiation, 
Lin28a controls the levels of neuro-specific miRNA-9 by destabilization of its 
precursor (Nowak et al. 2014). miRNA-9 is an ancient miRNA whose origin extends 
back to the transition toward triploblasts (Wheeler et al. 2009). In higher vertebrates, 
miRNA-9 has been directly linked with neuronal development. A genome-wide 
profiling of miRNA classified miRNA-9 as a brain-enriched miRNA (Lagos-Quintana 
et al. 2002; Krichevsky et al. 2003; Landgraf et al. 2007). Furthermore, its expression 
profiling suggests that miRNA-9 is dynamically regulated throughout neuronal 
differentiation (Miska et al. 2004; Sempere et al. 2004). Expression of miRNA-9 is 
switched on during mid-embryogenesis after the development of the neuronal scaffold 
and is associated with active neurogenic areas (Darnell et al. 2006; Walker and 
Harland 2008; Coolen et al. 2012). miRNA-9 is generally excluded from brain regions 
containing undifferentiated neuronal progenitors and from areas with late 
differentiation onset, such as the midbrain-hindbrain region and the retina (Leucht et 
al. 2008; La Torre et al. 2013). Moreover, REST and CREB regulate the transcription 
of miRNA-9 primary transcripts (Laneve et al. 2010). Previously we demonstrated 
that Lin28a binds to the CTL of pre-miRNA-9 and decreases the cellular levels of 
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miRNA-9 during retinoic acid-mediated neuronal differentiation of mouse 
teratocarcinoma P19 cells. We also showed that the Lin28a-mediated destabilization 
of pre-miRNA-9 is poly(U)-independent. Furthermore, constitutive expression of 
GFP-tagged Lin28a reduced the levels of let-7a but not miRNA-9, whereas untagged 
Lin28a inhibited both miRNA-9 and let-7a, leading to impaired neuronal 
differentiation. These results suggested that there are at least two distinct mechanisms 
by which Lin28a triggers pre-miRNA degradation and that both depend on the RNA 
substrate. Finally, because miRNA-9 regulation takes place in the first days of 
neuronal differentiation, it is unknown if there are other Lin28a-regulated miRNAs 
with discrete spatio-temporal expression during cellular differentiation.  
 
Here, we present molecular and biophysical evidence that Lin28a uses two distinct 
modes of binding to pre-let-7a and pre-miRNA-9, which could explain its alternative 
mechanisms of action. We reveal that 3’-5’exoribonuclease Dis3l2 contributes to the 
regulation of miRNA-9 levels. Using small RNAseq analysis of P19 cells with 
constitutive expression of Lin28a, we show that Lin28a controls production of many 
more miRNAs than previously recognized. We identified several miRNAs that are 
upregulated by Lin28a overexpression. Importantly, our high-throughput results 
confirm the limited function of GFP-tagged Lin28a and show that untagged Lin28a 
inhibits the production of a number of brain-specific miRNAs, including miRNA-9. 
Our results provide evidence that Lin28a has both positive and negative roles in the 
regulation of miRNA production and uses distinct mechanisms of binding to RNA. 
 
MATERIALS AND METHODS 
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Stable cell line generation 
P19 cell lines with stable Lin28a-GFP or GFP-only expression were gifts from Dr. 
Eric Moss (Rutgers School of Biomedical and Health Sciences, formerly The 
University of Medicine and Dentistry, New Jersey, USA) The University of 
Medicine and Dentistry, New Jersey) (Balzer et al. 2010). Both lines were 
maintained under standard culture conditions. A P19 cell line expressing untagged 
Lin28a was developed using the Flp-in system (Life Technologies), according to the 
manufacturer’s instructions and as previously described (Nowak et al. 2014).  
 
Cell culture and neuronal differentiation conditions 
Mouse teratocarcinoma P19 cells and HeLa cells were grown in standard DMEM 
medium (Life Technologies) supplemented with 10% FBS (Life Technologies). All-
trans retinoic acid (RA) (Sigma) was used to induce neuronal differentiation. In short, 
~12×106 cells were plated on a non-adhesive dish in DMEM supplemented with 5% 
serum and with 1 µM RA. This induced the formation of embryonic bodies. After 4 
days, the embryonic bodies were seeded in 10% FBS DMEM on an adhesive dish. 
Differentiation was followed up to 9 days post-induction. Plasmids encoding 
truncated Lin28a constructs were based on the pCG-T7-Lin28a construct previously 
described (Michlewski and Caceres 2010) and were prepared using inverted PCR. 
Plasmids were transfected into HeLa cells using Lipofectamine 2000 reagent, as 
previously described (Choudhury et al. 2014).  
 
Immunofluorescence  
Lin28a was visualized in P19 cells using primary monoclonal rabbit polyclonal anti-
Lin28a (A177) (Cell Signaling Technology). Prior to microscopy, cells were plated on 
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cover slips coated with 2 mL of 10 µg/mL PDL (Sigma-Aldrich P4707). At 24 h after 
plating, the cells were washed with PBS and fixed with 4% formaldehyde (Sigma-
Aldrich 37% w/v in H2O 252549-500) for 10 minutes at RT.  Next, the cells were 
permeabilized for 10 min at RT by adding 0.2% Triton-X (Sigma-Aldrich T9284-100). 
Subsequently, the cells were blocked for 15 min at RT with goat serum and incubated 
for 1 h at RT with primary antibody at a 1/1000 dilution in goat serum and for 1 h at 
RT with Alexa Fluor goat anti-rabbit 568 secondary antibody (Molecular Probes A-
11036) at a dilution of 1/1000 in goat serum. In the last step, cells were counterstained 
with Hoechst dye (1/20000) for 15 min at RT and mounted on slides using 15 µL of 
mounting medium (Molecular Probes Prolong Gold AntiFade P36930). Each of the 
above steps was separated by 3 washes with PBS for 5 min at RT. Mounted cells were 
visualized using a Zeiss Axio Imager Z1 fluorescent microscope. 
 
miRNA qRT-PCR analysis 
miRNA qRT-PCR analysis was performed using the miScript qRT-PCR kit (Qiagen) 
on total RNA isolated with TRIzol reagent (Life Technologies), and each sample was 
run in duplicate. To assess the levels of the corresponding microRNAs, values were 
normalized to miRNA-16. For each measurement, three independent experiments 
were performed. 
 
Small RNA sequencing 
Total cell RNA was extracted with TRIzol reagent and was subjected to quality 
control (QC) for SOLEXA sequencing (BGI Genomics). After a positive QC result, 
RNA was run on a PAGE gel, and species below 30 nt were extracted and ligated to 
SOLEXA adaptors at the 5’ and 3’ ends. Small RNA molecules were amplified for 17 
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cycles using PCR primers against SOLEXA adaptors, and fragments of approximately 
90 bp (small RNA + adaptor) were gel-purified and used directly for cluster 
generation and sequencing analysis using an Illumina Genome Analyzer. The image 
files generated by the sequencer were then processed to produce digital-quality data. 
The raw data were processed to generate clean reads by masking the adaptor 
sequences and removing contaminated reads (rRNA, tRNA, mRNA). Clean reads 
were mapped with zero-matches allowance onto a reference mouse genome using 
BGI-designed SOAPaligner software to locate each read on the genome sequence (Li 
et al. 2008). Subsequent annotation was performed using information in miRBase.  
 
Western blot analysis 
Total protein samples (100 µg per lane) were run on 4-12% NuPAGE SDS-PAGE 
electrophoresis with MOPS running buffer (Life Technologies) and were transferred 
onto a nitrocellulose membrane. The membrane was blocked overnight at 4°C with 
1:10 Western Blocking Reagent (Roche) in TBS buffer with 0.1% Tween-20 - TBST. 
The next day, the membrane was incubated for 1 h at RT with primary antibody 
solution in 1:20 Western Blocking Reagent diluted in TBST: rabbit polyclonal anti-
Lin28a (A177) (1:1000, Cell Signaling Technology), rabbit polyclonal anti-Dis3l2 
(1:1000, a kind gift from Andrzej Dziembowski), rabbit polyclonal anti-Exosc3 
(1:2000, Abcam), and mouse-monoclonal anti–β-tubulin (1:10,000, Sigma) and rabbit 
polyclonal anti-DHX9 (1:1000, Abcam). After washing in TBST, the blots were 
incubated with the appropriate secondary antibodies conjugated to horseradish 
peroxidase and were detected with SuperSignal West Pico detection reagent (Thermo 
Scientific). The membranes were stripped using ReBlot Plus Strong Antibody 
Stripping Solution (Chemicon) equilibrated in water, blocked in 1:10 western 
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blocking solution in TBST and re-probed, as described above. 
 
EMSA 
Electrophoretic mobility shift assays (EMSA) were performed with internally labeled 
pre-miRNA transcript and proteins produced in E. coli. Gel-purified probes (50×103 
c.p.m. (counts per minute), ~20 pmol) were incubated in 15-µl reaction mixtures 
containing the indicated amounts of proteins in Roeder D buffer (100 mM KCl, 20% 
(v/v) glycerol, 0.2 mM EDTA, 100 mM Tris at pH=8.0, 0.5 mM DTT, 0.2 mM 
PMSF) supplemented with 0.5 mM ATP, 20 mM creatine phosphate, and 3.2 mM 
MgCl2. Reactions were incubated at 4°C for 1 h followed by electrophoresis on a 6% 
(w/v) non-denaturing gel. The signal was registered with radiographic film or was 
exposed to a phosphoimaging screen and scanned on a FLA-5100 scanner (Fujifilm). 
 
RNA pull-down  
RNA pull-down was performed as previously described (Choudhury et al. 2014). In 
brief, total protein extracts from P19 or HeLa cells were incubated with in vitro-
transcribed RNAs chemically coupled to agarose beads. The incubation was followed 
by a series of washes with buffer G (20 mM Tris pH 7.5, 135 mM NaCl, 1.5 mM 
MgCl2, 10% (v/v) glycerol, 1 mM EDTA, 1 mM DTT and 0.2 mM PMSF). After the 
final wash, the proteins associated with the beads were analyzed by SDS–PAGE, 
followed by western blotting. 
 
In vitro processing assays 
Pre-miRNA substrates were prepared as previously described (Nowak et al. 2014). In 
brief, transcripts were prepared by in vitro transcription with [alpha-32P]-UTP. Gel-
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purified substrates (20×103 c.p.m. (counts per minute), ~20 pmol) were incubated in 
30 µl reaction mixtures containing Roeder D buffer, 0.5 mM ATP, 20 mM creatine 
phosphate, and 3.2 mM MgCl2. 5 µl were aliquoted for a control and 1 µg of Dis3l2 (a 
kind gift from Andrzej Dziebmowski and Krystian Stodus (Lubas et al. 2013)) 
recombinant proteins was added to the remaining reaction mixture. Then the reactions 
were incubated at 37°C. The reactions were stopped after 5, 10, 20 and 40 min 
followed by aliquoting 5 µl and quenching on ice with 5 µl of 2x (Urea Dye – UED), 
and followed by 8% (w/v) denaturing gel electrophoresis. Reactions with various 
amounts of Dis3l2 were performed for 10 min. The signal was registered with a 
radiographic film or by exposure to a phosphoimaging screen and scanning on a FLA-
5100 scanner (Fujifilm). 
 
RNA interference  
Pools of siRNAs were obtained from Dharmacon in the format of four independent 
siRNAs targeting different regions of the mRNA coding for the protein of interest. 
Four micrograms of siRNAs were delivered in two transfection events separated by 




Pre-miRNA-9 and pre-let-7a-1 substrates were synthesized by T7 in vitro 
transcription and were 5’ labeled with PKA, as described above. A formamide ladder 
was generated by incubating 2 µl of substrate (100×103 c.p.m.) with 9 µl of F buffer 
(0.5 mM MgCl2 in 99.5% formamide (Molekula Deutschland Limited)) at 100°C for 
10 min. The reaction was stopped by adding 9 µl of 2x (Urea Dye – UED) and was 
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placed on ice. The T1 ladder was generated by incubating 2 µl of substrate (100×103 
c.p.m.) with 2 µl of T1 2x buffer (20 mM sodium citrate, 7 M urea). One microliter of 
T1 at 1U/µl was added and incubated at 55°C for 15 min. The reaction was stopped 
by adding 15 µl of 2xUED and placing on ice. Probes were added for cleaving the 
substrate RNA Pb(II) at 0.2, 0.3, and 0.4 mM, ribonuclease T1 at 0.5 U/µl, 0.25 U/µl, 
0.125 U/µl and ribonuclease V1 at 0.00075 U/µl, 0.000375 U/µl, and 0.00019 U/µl. 
Each reaction was prepared with 1 µl of RNA (50×103 c.p.m.) and 7 µl of 1x structure 
buffer (12 mM Tris-HCl at pH=7.5, 48 mM NaCl, 1.2 mM MgCl2). Samples were 
unfolded at 90°C for 1 min and left at RT for 5 min to refold. Two microliters of 
probes were incubated with 8 µl of substrate solution at RT or 37°C for 10 min. 
Reactions were run in the presence and absence of the recombinant Lin28a protein. 
For cleavage optimization, 200 ng/µl of Lin28a protein was used. In the final 
experiments with fixed probe concentrations, Lin28a was used in a gradient of 50, 
100 and 200 ng/µl. Reactions were stopped by adding 10 µl of 2xUED and placing on 
ice. Samples were resolved on 10% polyacrylamide gel. The signal was registered 
with a radiographic film or via exposure to a phosphoimaging screen and then 
scanned on a FLA-5100 scanner (Fujifilm). 
 
Biolayer interferometry 
BLI experiments were performed in 10 mM Tris pH 8.5, 150 mM NaCl, 1 mM DTT, 
0.5 mg/ml BSA, and 0.1% Tween on an Octet Red 96 instrument (ForteBio, Inc. 
Menlo Park, CA) operating at 30°C. Streptavidin-coated biosensors bound to 
biotinylated pre-miRNA-9 or pre-let-7a-1 RNAs (0.125 ng/ml solutions) were 
exposed to different concentrations of Lin28a (with concentration series at 6.4 – 0.2 
µM for both pre-let-7a-1 and pre-miRNA-9, repeated with a concentration series of 
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0.4 – 0.0125 µM for pre-miRNA-9 and 1.6 – 0.05 µM for pre-let-7a-1). Dissociation 
constants for wild type and mutant binding were determined by plotting the increase 
in the Response Unit at equilibrium as a function of the protein concentration and 
fitting using nonlinear regression and in-house software. 
 
Preparation of recombinant Lin28a 
Full-length Lin28a (AF521099) were cloned into pETM-11 vector (EMBL-
Heidelberg, Protein Expression Facility), introducing TEV protease-cleavable HisTag 
N-terminal to the insert. The HisTag fusion protein was purified from the soluble 
fraction by nickel-affinity chromatography (Qiagen), after TEV cleavage another 
nickel-affinity chromatography step was introduced to remove the cleaved His-tag, 
followed by gel filtration. The final protein was concentrated to 100µM and stored in 




Lin28a uses different modes of binding to pre-miRNA-9 and pre-let-7. 
Undifferentiated cells do not produce let-7 or miRNA-9 due to posttranscriptional and 
transcriptional control, respectively (Nowak et al. 2014). Lin28a binds to pre-let-7 and 
triggers uridylation-dependent degradation (Heo et al. 2009; Chang et al. 2013; 
Ustianenko et al. 2013). In the course of neuronal differentiation gradual reduction of 
Lin28a expression allows de-repression of let-7 biogenesis in more developed and 
differentiated cells (Seggerson et al. 2002; Moss and Tang 2003; Darr and Benvenisty 
2009; Van Wynsberghe et al. 2011). Pri-miRNA-9 starts being produced at day 3 of 
differentiation but mature miRNA-9 only starts to accumulate from day 4. Previously 
we showed that Lin28a triggers uridylation-independent degradation of pre-miRNA-9 
and regulates miRNA-9 levels in early stages of differentiation, or when misexpressed 
(Nowak et al. 2014). Furthermore, we have shown that prolonged expression of 
Lin28a results in defective retinoic acid-driven neuronal differentiation. 
 
To determine the differences between pre-miRNA-9/Lin28a and pre-let-7a/Lin28a 
complexes, we performed RNA structure probing with lead ions and T1 and V1 
ribonucleases. With pre-let-7a-1, there was a significant Lin28a footprint around the 
well-known AGGG and GGAG Lin28a-binding motifs, which are located in the 
conserved terminal loop (Figure 1A,C). These regions have been previously shown by 
structural studies to interact, respectively, with the cold-shock (CSD) and zinc-finger 
(ZnF) domains of Lin28a (Lightfoot et al. 2011; Nam et al. 2011; Desjardins et al. 
2012; Loughlin et al. 2012). Binding of recombinant Lin28a resulted in increased 
cleavage by V1 ribonuclease with decreased activity of Pb(II) cleavage in the central 
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region of the terminal loop, which suggests structural rearrangements of the pre-let-
7a-1 structure (Figure 1A,C). For pre-miRNA-9, the most significant Lin28a footprint 
was identified within the GU-rich region of its conserved terminal loop but not the 
GGAG motif (Figure 1B,D). Similarly to pre-let-7a-1, association of Lin28a resulted 
in increased activity of V1 ribonuclease, which suggests higher order structural 
rearrangements.  
 
Isolated CSD of Lin28a can bind to pre-miRNA-9 but not to pre-let-7. 
To establish if pre-miRNA-9 interaction with Lin28a is indeed different compared to 
that observed in the case of pre-let-7a-1, we performed pull-down assays in HeLa cell 
extracts with various overexpressed, truncated forms of Lin28a (Figure 2). Both pre-
miRNA-9 and pre-let-7a-1 pulled down nearly full-length 1-209 and N and C termini 
truncated 24-190 Lin28a (Figure 2A,B). Notably, pre-miRNA-9 pulled down CSD-
containing peptide constructs 1-123 and 24-123 much more efficiently than pre-let-
7a-1 (Figure 2C). In particular, pre-let-7a-1 did not pull down the CSD-containing 
peptide 24-123 at all whereas binding of this peptide to pre-miRNA-9 was detected at 
approximately 72% of the signal from the loading control (Figure 2C). This is in line 
with previous observations showing significantly weaker interaction of CDS with pre-
let-7g when compared with the full-length Lin28a (Desjardins et al. 2012). At the 
same time, pre-let-7a-1 was able to pull down truncated Lin28a with ZnF domain 
(123-209) twice as efficiently as pre-miRNA-9 (Figure 2C) and more efficiently than 
the full-length Lin28a. Surprisingly, Desjardins et al. showed similar affinity of 
isolated ZnF domain and full-length Lin28a to pre-let-7g (Desjardins et al. 2012). 
This could be due to different accessibility of Lin28a-binding motifs in the terminal 
loops of pre-let-7a-1, pre-let-7g and pre-miRNA-9. Two other constructs (1-74, 156-
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209) showed some degree of differential binding affinity between pre-miRNA-9 and 
pre-let-7a-1. These results strongly suggest that pre-miRNA-9 and pre-let-7a-1 bind 
Lin28a using different domains. 
 
GGAG motif is not responsible for Lin28a binding to pre-miRNA-9. 
To compare the binding affinity of Lin28a for pre-miRNA-9 and pre-let-7a-1 and to 
investigate the role played by the ZnF and Cold Shock domains in RNA recognition 
in more detail we designed an assay orthogonal to the pull downs described above. 
We disrupted the ZnF-RNA interactions by mutating the ZnF target RNA sequence 
(GGAG to UUUU) in the terminal loops of pre-miRNA-9 and pre-let-7a-1 (Figure 
3A,B) and used BioLayer Interferometry (BLI) to probe changes in RNA binding 
(Figure 3C,D). We immobilized biotinylated pre-miRNA-9 and pre-let-7a-1 on 
streptavidin BLI sensors and assessed their interaction with recombinant Lin28a. 
Lin28a co-purifies with non-specific nucleic acid; therefore, our assays were 
effectively competition experiments rather than two-way component experiments. 
This showed that Lin28a binds both pre-miRNA-9 and pre-let-7a-1 with a kd in the 
high nanomolar range (~300 nM and ~400 nM, respectively) (Figure 3C,D). Previous 
reports of Lin28a dissociation constants with fragments from pre-let-7 substrates were 
in the range of 0.15nM to 15µM (Piskounova et al. 2008; Lightfoot et al. 2011; Nam 
et al. 2011; Desjardins et al. 2012). The differences most likely arise from presence or 
absence of RNA competitors in the binding buffers and different RNA substrates 
tested. Our experiments showed that mutation of the canonical ZnF binding site 
GGAG to UUUU led to a significant decrease in Lin28a binding to pre-let-7a-1 of 
more than tenfold (mutant kd is >>6 µM, Figure 3D), but not in Lin28a binding to pre-
miRNA-9 (kd is still ~300 nM, Figure 3C). Importantly, GGAG/UUUU mutation did 
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not abrogate inhibitory activity of Lin28a on pre-miRNA-9 in HeLa cells 
(Supplementary Figure 1). Altogether, these results confirm that Lin28a recognizes 
the two RNAs in a different manner, with the CSD playing a more prominent role in 
the recognition of pre-miRNA-9 and the ZnF being essential in the recognition of pre-
let-7a.  
 
EMSA with recombinant Lin28a validates BLI assays. 
In order to validate BLI assays we used EMSA with radiolabeled pre-miRNA probes 
and increasing amounts of recombinant Lin28a (Figure 4). Both pre-miRNA-9 and 
pre-miRNA-9 mt were shifted by the Lin28a forming monomeric and multimeric 
complexes (Figure 4A). In line with our BLI experiments only wild-type pre-let-7a-1 
but not pre-let-7a-1 mt was efficiently shifted by the Lin28a (Figure 4B). The 
stepwise multimerization of Lin28a has been shown before and its believed to be 
important for inhibition of Dicer cleavage (Desjardins et al. 2014). Importantly, pre-
miRNA-16, which was shown by many groups not to bind Lin28a does not shift 
Lin28a efficiently (Figure 4C).  
 
Dis3l2 is involved in regulating levels of miRNA-9 during neuronal 
differentiation of P19 cells 
To determine whether RNA degradation enzymes can cooperate with Lin28a in the 
destabilization of pre-miR-9 during neuronal differentiation, we performed RNAi 
against Dis3l2 and Exosc3 (Figure 5A). Exosc3 is an essential, non-catalytic 
component (Liu et al. 2006) of the RNA exosome (Mitchell et al. 1997), which plays 
a pivotal role in the binding and presentation of RNA for degradation. Dis3l2 and 
Exosc3 were depleted by approximately 70% and 50%, respectively. Surprisingly, 
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Dis3l2 knockdown also resulted in downregulation of Exosc3. The miRNA levels 
were analyzed in P19 cells treated by siRNAs and subsequently differentiated until 
day 4 and were compared to reciprocal, mock-treated cells. At this stage both pri-
miRNA-9 and pri-let-7 are transcribed but Lin28a suppresses their processing. As 
previously reported, Dis3l2 knockdown had no significant effect on mature let-7 
(Chang et al. 2013) (Figure 5B). This is mainly due to pre-let-7a poly(U) tail, which 
inhibits Dicer processing (Heo et al. 2009). The same Dis3l2 knockdown resulted in a 
subtle but reproducible increase in miRNA-9 levels (Figure 5B). It is important to 
note that expression of miRNA-9 only starts at day 3 of P19 cell neuronal 
differentiation (Nowak et al. 2014), hence the observed small changes in miRNA-9 
expression. Additionally, due to Dicer inability to process uridylated pre-let-7a it was 
stabilized 20-fold in Dis3l2 knockdown (Figure 5C). Conversely, levels of pre-
miRNA-9 were unaffected by Dis3l2 depletion. Unconstrained Dicer processing of 
the stabilized pre-miRNA-9 could explain the lack of stabilization of pre-miR-9 upon 
Dis3l2 knockdown. The Exosc3 knockdown had no effect on the levels of either 
mature miRNA-9 or let-7 (Figure 5B) but resulted in 3-fold upregulation of pre-let-7 
(Figure 5C). These results suggest that Dis3l2, but not the RNA exosome, plays a role 
in the downregulation of miRNA-9 levels. 
 
To determine whether Dis3l2 interacts with pre-miRNA-9 in an poly(U)-independent 
manner, we performed RNA pull-down assays in extracts derived from 
undifferentiated P19 cells (Figure 5D). To see if the interaction was specific, we used 
pre-let-7a-1 as a control because it was previously reported to require a poly(U) tail 
for efficient Dis3l2 binding (Chang et al. 2013). Our chemical coupling method of 
RNA to agarose beads via 3’ ribose protects the RNA from 3’ uridylation. As 
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described before, (Nowak et al. 2014) both pre-miRNA-9 and pre-let-7a-1 interacted 
with Lin28a (Figure 5D). However, only pre-miRNA-9 pulled-down Dis3l2 in a 
uridylation-independent manner. This is surprising as Dis3l2 was shown to bind 3’ 
ends of RNAs with preference towards multiple U residues (Faehnle et al. 2014). 
Furthermore, pre-let-7a_(U)15, pre-miRNA-9_(U)15 and pre-miRNA-9 mt but not 
pre-let-7a-1 mt pulled-down Dis3l2 with similar efficiency (Figure 5E). We also 
noted that pre-miRNA-9 mt shows increased binding to Dis3l2 (Figure 5E) compared 
to pre-miRNA-9 (Figure 5D). This could be due to the fact that the pre-miRNA-9 mt 
has additional U residues in the terminal loop, which might have created a Dis3l2 
binding site. Altogether, these results indicate that complexes between Lin28a, Dis3l2 
and pre-miRNAs can be formed even in the absence of a poly(U) tail and that the 
complexes formed by pre-miRNA-9 and pre-let-7a are different. 
 
Dis3l2 destabilizes pre-miRNA-9 in vitro. 
Previously, we showed that pre-miRNA-9 is destabilized at the early stages of P19 
cell neuronal differentiation (Nowak et al. 2014). To determine whether Dis3l2 is 
directly responsible for the role in pre-miRNA-9 degradation, we performed in vitro 
cleavage assays using recombinant Dis3l2 (Lubas et al. 2013). For pre-miRNA-9 and 
pre-miRNA-9 mt addition of recombinant Dis3l2 resulted in robust time and 
concentration-dependent RNA degradation (Figure 6A,C). Dis3l2 did not affect the 
control pre-miRNA-16 in similar conditions (Figure 6A-D). At the same time, the 
artificial pre-miRNA-9_(U)15 and pre-let-7a-1_(U)15 were fully degraded after 5 
minutes of incubation, confirming that Dis3l2 prefers U-tailed substrates (Figure 6A, 
B). Importantly, Dis3l2 activity on the pre-let-7a-1 and pre-let-7a-1 mt substrates was 
markedly lower, as compared to pre-miRNA-9 (Figure 6B). For example, after 10 
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minutes of incubation we recovered less than 10% of pre-miRNA-9 substrate and 
more than 40% of pre-let-7a-1 substrate (Figure 6A,B). Furthermore, Dis3l2 titration 
revealed that pre-miRNA-9_(U)15 is degraded more efficiently than pre-let-7a-
1_(U)15 (Figure 6C,D). Altogether, these results demonstrate that pre-miRNA-9 RNA 
is a good substrate for Dis3l2. Surprisingly, addition of recombinant Lin28a slowed 
down Dis3l2-mediated degradation of pre-miRNA-9 and pre-let-7a-1 (Supplementary 
Figure 2). This might be a consequence of lack of eukaryotic-specific protein 
modifications or absence of additional, yet uncharacterized cofactors. Thus, it remains 
to be established how Dis3l2 cooperates with cofactors, such as Lin28a, whose 
depletion leads to pre-miRNA-9 stabilization (Nowak et al. 2014). In summary, these 
results show that Dis3l2 could be directly involved in the degradation of pre-miRNA-
9.  
 
Constitutive expression of untagged Lin28a deregulates the levels of many 
miRNAs during neuronal differentiation of P19 cells 
Our previous findings demonstrated that prolonged expression of Lin28a impairs 
neuronal differentiation and miRNA-9 biogenesis (Nowak et al. 2014). Here, to 
determine which additional miRNAs are missexpressed upon constitutive Lin28a 
expression, we performed small RNA sequencing in samples derived from 
undifferentiated (day 0 – d0) and differentiated (day 9 – d9) control P19 cells and 
cells that constitutively express GFP-tagged (at the C-terminus) or untagged Lin28a 
(Figure 7), as previously described (Nowak et al. 2014). We compared the expression 
level changes of mature miRNAs, represented by the d9/d0 ratio, in P19 Lin28a and 
P19 Lin28a GFP cells to the changes in the reciprocal untargeted P19 FRT and P19 
GFP control cell lines. We observed that the constitutive expression of untagged 
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Lin28a but not of GFP-tagged Lin28a had a profound impact on the levels of many 
mature miRNAs during P19 cell neuronal differentiation, including miRNA-9 (Figure 
7A,B). Interestingly, other brain-enriched miRNAs, such as miRNA-124 and miRNA-
138, were also negatively affected by Lin28a expression (Supplementary Figure 3). 
Due to its impaired function, the effects of the constitutive expression of GFP-tagged 
Lin28a were much more modest and extended to fewer miRNAs (Figure 7A), 
including let-7a (Figure 7B).  
 
To further analyze our data, we selected miRNAs that were regulated more than 2-
fold by the constitutive expression of untagged Lin28a but were not affected (less 
than a 2-fold change) by GFP-tagged Lin28a (Figure 7A and Supplementary Figure 3). 
Apart from the 54 miRNAs that were downregulated by 2- to 6-fold, we observed 110 
miRNAs that were upregulated from 2- to 95-fold by the constitutive expression of 
Lin28a but not GFP-Lin28a (Supplementary Figure 3). This implies that Lin28a can 
negatively and positively impact the production of many miRNAs. Importantly, 
miRNA-9 was one of the most downregulated miRNAs by untagged Lin28a, which 
corroborates our previous findings (Nowak et al. 2014). To validate the small 
RNAseq results, we measured the levels of selected miRNAs by qRT-PCR. The levels 
of miRNA-9 were significantly suppressed by constitutive Lin28a expression only 
(Figure 7B), whereas let-7a expression was suppressed by both untagged and GFP-
tagged Lin28a (Figure 7B). Our previous data showed that the differences between 
untagged and GFP-tagged Lin28a do not arise from different protein levels (Nowak et 
al. 2014). Now we extend this to show that both untagged and GFP-tagged Lin28a 
(Figure 7C) have identical cytoplasmic localization (Figure 7D). This is in line with 
previous studies, which showed predominantly cytoplasmic localization of Lin28a 
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(Moss and Tang 2003; Balzer and Moss 2007; Balzer et al. 2010). This reinforces the 
notion that the presence of the GFP tag interferes with Lin28a function on some 
miRNA precursors, such as miRNA-9, but not on others, such as let-7a. Lin28a 
crystal structure shows the C-terminus extending towards CSD (Nam et al. 2011). 
Thus, we speculate that the GFP tag, which is placed at the C-terminus of Lin28a, can 
interfere with CSD binding. This also agrees with our biochemical observations about 
different structural arrangements of pre-miRNA-9/Lin28a and pre-let-7a/Lin28a 
complexes. 
 
Forced expression of Lin28a results in upregulation of many miRNAs. 
Surprisingly, levels of some miRNAs were elevated by constitutive expression of 
untagged Lin28a and remained relatively unchanged in the GFP-tagged Lin28a P19 
cell line (Figure 7 and Supplementary Figure 3). For validation we chose miRNA-182 
and miRNA-541 as they represented miRNAs upregulated by untagged Lin28a but 
not by GFP-tagged Lin28a. We validated the expression of miRNA-182 and miRNA-
541 by qRT-PCR and observed that their levels were indeed higher in the presence of 
constitutively expressed Lin28a (Figure 8A). Importantly, both pre-miRNA-182 and 
pre-miRNA-541 were able to pull-down Lin28a from day 0 P19 cell extracts with 
similar efficiency to pre-let-7a-1 (Figure 8B). Whereas pre-miRNA-16 did not pull 
down Lin28a. Furthermore, Lin28a efficiently shifted both pre-miRNA-182 and pre-
miRNA-541 in EMSA (Figure 8C). However, transient Lin28a depletion in 
undifferentiated P19 cells did not result in a significant change in the levels of mature 
miRNA-182 and miRNA-541 (Supplementary Figure 4). This suggests the existence 
of additional mechanism safeguarding their biogenesis in undifferentiated cells. 
Alternatively, the positive effects on miRNA levels could be indirect. The exact 
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mechanism(s) underlying the Lin28a-mediated upregulation of miRNAs have yet to 
be determined. 
 
Lin28a binding sites are enriched in primary transcripts of Lin28a-affected 
miRNAs. 
Finally, to determine if Lin28a binding motifs, previously revealed by CLIP analysis 
(Wilbert et al. 2012), are present in the primary transcripts of Lin28a-affected 
miRNAs (miRNAs regulated more than two-fold up or down by untagged Lin28a but 
not regulated by GFP-tagged Lin28a), we performed bioinformatics analysis on a 
500-nt sequence window surrounding the analyzed pre-miRNAs. We found that 
several Lin28a CLIP-motifs, including AAGAAA, GAGAAA and GGGAAC, were 
enriched in proximity to the miRNAs upregulated by Lin28a (Figure 9A). Whereas, 
other motifs, including AGGAGG, GCGGAG and GCGGAC were enriched in 
proximity to the miRNAs downregulated by Lin28a (Figure 9A). Intriguingly, 
precursors of both miRNA-182 and miRNA-541, which were upregulated by Lin28a 
have AGAA motifs within their stems (Supplementary Figure 4). Notably, different 
CLIP-motifs, including CAGGAG, were depleted from both up and downregulated 
miRNAs (Figure 9A). These findings indicate that Lin28a might exert different 
mechanisms depending on the sequences that it binds to (Nowak et al. 2014). To 
determine if the distribution of the Lin28a-CLIP motifs is significant, we randomized 
the 500-nt sequence windows surrounding the Lin28a-up and downregulated and all 
analyzed miRNAs (Figure 9A,B). Both sets of randomized pri-miRNA sequences 
showed no enrichment of Lin28a-CLIP motifs, which suggests that there is a selective 
pressure to keep Lin28a binding motifs in proximity to the miRNA loci and that the 
role of Lin28a or other protein(s) that use similar binding motifs, in miRNA 
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biogenesis could be more systemic and widespread. In summary, these results suggest 
that functional differences in Lin28a’s mode of action may depend on the nature of its 
molecular interactions with the miRNA progenitor transcripts.  
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DISCUSSION 
At least three independent, genome-wide studies have shown a broad range of Lin28a 
targets (Cho et al. 2012; Wilbert et al. 2012; Hafner et al. 2013). In the majority of 
cases, Lin28a was shown to interact with mRNA, whereas snoRNA and miRNA were 
minor targets (Hafner et al. 2013). However, these studies concentrated on RNA-
protein interactions either in undifferentiated embryonic stem cells or differentiated, 
well-established cell models, such as HEK293 (Cho et al. 2012; Wilbert et al. 2012). 
In our study, we showed that constitutively expressed Lin28a regulates production of 
many other miRNAs during the retinoic acid-driven neuronal differentiation of mouse 
P19 cells. More miRNAs were up-regulated than down-regulated, suggesting that 
Lin28a exerts a positive role in miRNA production. Importantly, it remains to be 
elucidated whether these results were achieved by direct or indirect mechanisms. This 
could be done for example with newly identified small molecule inhibitors of Lin28a 
(Lim et al. 2016; Roos et al. 2016) in cellular systems as well as using in vitro binding 
assays. That said, many pre-miRNAs affected by Lin28a, such as pre-miRNA-9, -34c 
or -181a, have already been shown to be good substrates for Lin28a binding (Towbin 
et al. 2013). Under physiological conditions, Lin28a is predominantly expressed at the 
early stages of cellular differentiation; therefore, for miRNAs to be affected by 
Lin28a they must be co-expressed at this stage. Both Lin28a and Lin28b are mis-
expressed in a number of tumor and cancer cells (Thornton and Gregory 2012; Zhou 
et al. 2013). It is now evident that Lin28a is an important oncogene in tumorigenesis 
(Tu et al. 2015) and an emerging maker of cancer stem cells (Ma et al. 2014). For 
example, prolonged expression of Lin28a in primitive mesenchymal kidney cells 
resulted in increased cell proliferation and Wilms’ tumor formation (Feng et al. 2012), 
which strongly suggests that Lin28a-mediated regulation of miRNA production can 
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transcend the niche of undifferentiated cells and affect other miRNAs that are 
important for proper developmental timing. Thus, studying the systems where Lin28a 
is overexpressed is of utmost importance to understand its various roles in cancer 
biology. Interestingly, Dis3l2, which plays important role in Lin28a/let-7a pathway, is 
frequently mutated in Wilms’ tumor and causes the Perlman syndrome of overgrowth 
(Astuti et al. 2012; Reis et al. 2013). 
 
In our previous work, we observed a substantial delay between the pri-miRNA-9 
expression and the production of mature miRNA-9 during the neuronal differentiation 
of P19 cells. We also showed that Lin28a plays a role in restricting miRNA-9 
production to later stages of neuronal differentiation (Nowak et al. 2014). The 
mechanism that triggers pre-miRNA-9 degradation, which, similar to pre-let-7a-1, is 
dependent on the conserved terminal loop but, unlike pre-let-7, is poly(U)-
independent. In the case of pre-let-7 Lin28a binding attracts TUT4 and TUT7, which 
catalyze the addition of a poly(U) tail to its 3’ end (Hagan et al. 2009; Thornton et al. 
2012) and subsequent degradation by Dis3l2 (Chang et al. 2013; Ustianenko et al. 
2013), whereas binding of Lin28a to pre-miRNA-9 results in poly(U)-independent 
degradation (Nowak et al. 2014). Interestingly, both pre-miRNA-9 and pre-let-7a 
have the canonical Lin28a binding GGAG motif in their terminal loops. Our previous 
results showed that when the GGAG motif is present in a very small synthetic 
terminal loop it does not bind Lin28a (Choudhury et al. 2014). Hence, we propose 
that due to its structural architecture, pre-miRNA-9 predominantly interacts with 
Lin28a through its CSD domain, unlike in the case of pre-let-7, where both ZnF and 
CSD are involved in binding to the large terminal loop (Nam et al. 2011; Loughlin et 
al. 2012). Lin28 CSD binds with high affinity to single-stranded nucleic acids but 
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with limited sequence specificity (Mayr et al. 2012). In the terminal loops of pre-let-7 
it binds to GNGAY consensus sequence (Y, pyrimidine; N, any base) (Nam et al. 
2011). Surprisingly, the CSD of YBX2 protein binds well-defined AACA(A/U)C 
motif (Ray et al. 2013). Previously, it was shown that discrete structural and sequence 
differences in human pre-let-7a-2 (and its murine ortholog pre-let-7c-2) prevent 
Lin28a binding and bypass Lin28a-mediated inhibition (Triboulet et al. 2015). 
Furthermore, yeast three-hybrid analysis revealed that pre-let-7 transcripts bind using 
both CSD and ZnF but other pre-miRNAs, such as pre-miRNA-152 or pre-miRNA-
302d bind Lin28a using CSD predominantly (Balzer et al. 2010). Altogether, we 
speculate that differential binding of Lin28a could lead to distinct pre-miRNP 
complex formation.  
 
Pre-miRNA-9 characteristics allow efficient binding of both Lin28a and Dis3l2 in a 
poly(U)-independent manner (Figure 5D). Moreover, recombinant Dis2l3 was able to 
efficiently cleave pre-miRNA-9 in vitro (Figure 6A). However, synthetically 
polyuridylated pre-miRNA-9 is a better substrate for Dis3l2 (Figure 6A). This agrees 
with previous results that Dis3l2 prefers uridylated substrates but can degrade many 
other transcripts (Lubas et al. 2013; Malecki et al. 2013). Dis3l2 RNAi resulted in 
moderate but highly reproducible upregulation of miRNA-9 during early 
differentiation of P19 cells (Figure 5B) but did not influence steady state pre-miRNA-
9 levels (Figure 5C). We speculate that upon Dis3l2 knockdown pre-miRNA-9 could 
be stabilized and thus provide more substrate for Dicer cleavage, which would 
generate more mature miRNA-9. So far there are no reports of direct interaction 
between Lin28a and Dis3l2. Notably, Lin28a is well-known to recruit TUT4 to pre-
let-7, however, there is no evidence of physical interactions between Lin28a and 
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TUT4. Instead, it is suggested that Lin28a functions as a TUT4 processivity factor 
(Yeom et al. 2011). In the future it will be important to test if the same could be true 
for Dis3l2. A recent report has shown that Dis3l2 is involved in degradation of 
miRNAs, which are bound by highly complementary target RNAs (Haas et al. 2016). 
Further in-depth characterization of the pre-miRNA-9/protein complex is required to 
reveal the fine details of this interaction. 
 
Lin28a is important for neuronal differentiation (Rybak et al. 2008; Balzer et al. 2010). 
Here, we show that its prolonged expression in differentiating cells positively and 
negatively affects numerous miRNAs. Furthermore, we present evidence that small 
differences in RNA secondary structures, such as those seen between the stem loops 
of pre-let-7a and pre-miRNA-9, could determine the mode of RNA-binding protein 
interaction and RNP function. In summary, our results increase understanding 
regarding the ways in which RNA-protein interactions control RNA metabolism in 
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Figure 1. Footprinting analysis of the Lin28a interaction with pre-let-7a-1 and pre-
miRNA-9. (A,B) Structure probing and footprint analysis of the pri-miRNA-9 and 
pre-let-7a-1 in complex with Lin28a. Cleavage patterns were obtained for 5’ 32P-
labeled transcripts incubated in the absence (Lanes 3 to 6) or in the presence of 
increasing amounts of recombinant Lin28a (Lanes 7 to 18) (100 ng, 200 ng, 500 nM), 
treated with ribonuclease T1 (lanes 7 to 10), Pb (II)-lead ions (lanes 11 to 14) and 
ribonuclease V1 (lanes 15 to 18). FL (lanes 1) and T1L (lanes 2) denote nucleotide 
residues subjected to partial digestion with formamide (every nucleotide) or 
ribonuclease T1 (G-specific cleavage). Electrophoresis was performed in a 12% 
polyacrylamide gel under denaturing conditions. The positions of the selected G 
residues are indicated. Nucleotides are numbered from the 5′ site of Drosha cleavage. 
(C,D) Proposed structures of free and Lin28a-bound pri-miRNAs. The sites and 
intensities of cleavage generated by structure probes are shown. The green 
nucleotides represent the nucleotides with the most significant Lin28a footprint. 
 
Figure 2. Lin28a binds to pre-miRNA-9 and pre-let-7a-1 using different domains. 
(A,B) Western blot analysis of pre-miRNA-9 and pre-let-7a-1 pull-downs with HeLa 
cell extracts overexpressing human Lin28a and its truncation mutants. Lanes with odd 
numbers represent 4% (100 µg) of the loading controls (I). Lanes with even numbers 
show the pull-down reactions (P). (C) Schematic representation of Lin28a truncations 
and relative binding efficiency, quantified as a percentage of the signal detected in the 
corresponding loading controls. The results are representative of at least three 




Figure 3. The two RNA binding domains of Lin28a play a different role in the 
recognition of pre-let-7a and pre-miRNA-9. (A,B) Secondary structures of wild type 
and GGAG/UUUU pre-miRNA-9 and pre-let-7a-1 mutants (mt). Mutated residues are 
marked in red. (C,D) BLI data reporting on Lin28 binding to pre-miR-9 (wild type 
and mutant) and pre-let-7-a (wild type and mutant) at a protein concentration of 0.4 
µM and 0.8 µM, respectively (E,F) The value of BLI signal at equilibrium upon 
exposing the immobilized RNAs to different concentrations of Lin28a are plotted 
against protein concentrations. The binding isotherms are also displayed. BLI data 
show that Lin28a binding to the pre-miRNA-9 RNA is only marginally affected by 
the mutation of the ZnF-specific sequence, whereas mutating the ZnF recognition 
sequence leads to a very significant drop in affinity for the pre-let-7a RNAs. 
 
Figure 4. Lin28a EMSA with pre-let-7a and pre-miRNA-9 confirms BLI results. (A) 
EMSA analysis with pre-miRNA-9 and pre-miRNA-9 mt. Lanes 1 represent the 
loading control. Lanes 2 to 4 show EMSA with increasing amount of Lin28a (50 ng, 
100 ng and 200 ng). (B) EMSA analysis with pre-let-7a-1 and pre-let-7a-1 mt. Lanes 
1 represent the loading control. Lanes 2 to 4 show EMSA with increasing amount of 
Lin28a (50 ng, 100 ng and 200 ng). (C) EMSA analysis with pre-miRNA-16. Lane 1 
represents the loading control. Lanes 2 to 4 show EMSA with increasing amount of 
Lin28a (50 ng, 100 ng and 200 ng). 
 
Figure 5. Dis3l2 affects miR-9 levels and binds pre-miR-9 in a poly(U)-independent  
manner. (A) Western blot analysis of protein extracts from mock-depleted P19 cells 
(Lane 1), Dis3l2-depleted P19 cells (Lane 2) and EXOSC3-depleted P19 cells (Lane 
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3). Lanes 4 through 8 show serial dilutions of total protein extracts from mock-
depleted P19 cells, providing an estimation of the linearity of the western blot assay 
and the limit of detection. Real-time qRT-PCR analysis of the mature (B) and pre (C) 
miRNA-9 and let-7a levels on day 4 of RA-induced neuronal differentiation. The 
results from the mock-depleted cells are shown as white bars; the results from Dis3l2-
depleted cells are shown as black bars; the results from EXPSC3-depleted cells are 
shown as gray bars. The values were normalized to miR-16 levels. The fold change 
was plotted relative to values derived from mock-depleted cells, which were set to 1. 
The mean and standard deviations (SD) of three independent biological replicates are 
shown. Statistical significance was calculated using a t-test (*) P≤0.05. (D) Western 
blot analysis of pre-miRNA pull-down with d0 P19 cell extracts for Dis3l2 and 
Lin28a. Lane 1 represents 4% (100 µg) of the loading control. Lane 2 shows the 
reaction with beads alone. Lanes 3 and 4 represent pre-miRNA-9 and pre-let-7a-1 
pull-downs, respectively. The results are representative of at least three independent 
experiments. (E) Western blot analysis of pre-miRNA pull-down with d0 P19 cell 
extracts for Dis3l2, Lin28a and DHX9. Lane 1 represents 4% (100 µg) of the loading 
control. Lane 2 shows the reaction with beads alone. Lanes 3, 4, 5 and 6 represent 
pre-let-7a-1 mt, pre-let-7a-1_(U)15, pre-miRNA-9 mt and pre-miRNA-9_(U)15 pull-
downs, respectively. The results are representative of at least three independent 
experiments. 
 
Figure 6. Dis3l2 destabilizes pre-miRNA-9 in vitro. Internally radiolabeled pre-
miRNA-9, pre-miRNA-9 mt, pre-miRNA-9_(U)15 and pre-miRNA-16 (A), pre-let-
7a-1, pre-let-7a-1 mt, pre-let-7a-1_(U)15 and pre-miRNA-16 (B) (3×103 c.p.m. 
(counts per minute), approximately 6 pmol) were incubated in the buffer only for 40 
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minutes (Lanes 1). Where indicated, 200 ng of recombinant Dis3l2 proteins was 
added to the reaction, which were run for 5, 10, 20 and 40 minutes. The products were 
analyzed on an 8% denaturing polyacrylamide gel. The results are representative of at 
least three independent experiments. The graphs represent quantification of 
substrate’s intensities. The values were plotted relative to the control reactions set to 
100. The mean and standard deviations (SD) of three independent experiments are 
shown. Internally radiolabeled pre-miRNA-9, pre-miRNA-9 mt, pre-miRNA-9_(U)15 
and pre-miRNA-16 (C), pre-let-7a-1, pre-let-7a-1 mt, pre-let-7a-1_(U)15 and pre-
miRNA-16 (D) (3×103 c.p.m. (counts per minute), approximately 6 pmol) were 
incubated for 10 minutes with increasing amount of Dis3l2 (0.2 ng, 2 ng, 20 ng, 200 
ng). The products were analyzed the same as described above. 
 
Figure 7. Constitutive expression of untagged Lin28a affects the levels of numerous 
miRNAs during RA-induced neuronal differentiation of P19 cells. (A) Scatterplots of 
the fold change between day 0 and day 9 of the neuronal differentiation of P19 cells 
with GFP-tagged Lin28a and GFP only (left graph) and of P19 cells with untagged 
Lin28a and the control cell line (right graph). miRNAs regulated more than two-fold 
up or down by untagged Lin28a but not regulated by GFP-tagged Lin28a are 
highlighted with red circles. (B) Real-time qRT-PCR analysis of mature miRNA-9 
and let-7a represented by fold change between d0 and d9. The values were 
normalized to miRNA-16 levels. The fold change was plotted relative to values 
derived from undifferentiated cells (d0), which were set to 1. The mean and standard 
deviations (SD) of three independent biological replicates are shown. Statistical 
significance was calculated using a t-test (*) P≤0.05. NS - statistically non-significant 
(C) Immunofluorescence staining of Hoechst (blue), Lin28a (green) in P19 cells 
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showing localization of both untagged and GFP-tagged Lin28a predominantly in the 
cytoplasm. Scale bar – 10µm. 
 
Figure 8. Constitutive expression of untagged Lin28a upregulates miRNA-541 and 
miRNA-182 during RA-induced neuronal differentiation of P19 cells. (A) Real-time 
qRT-PCR analysis of mature miRNA-541-5p and miRNA-182-5p represented by fold 
change between d0 and d9. The values were normalized to miRNA-16 levels. The 
fold change was plotted relative to values derived from undifferentiated cells (d0), 
which were set to 1. The mean and standard deviations (SD) of three independent 
biological replicates are shown. Statistical significance was calculated using a t-test 
(*) P≤0.05, (**) P≤0.005. (B) Western blot analysis of pre-miRNA pull-down with d0 
P19 cell extracts for Lin28a and DHX9. Lane 1 represents 4% (100 µg) of the loading 
control. Lane 2 shows the reaction with beads alone. Lanes 3, 4, 5 and 6 represent 
pre-miRNA-16, pre-let-7a-1, pre-miRNA-182 and pre-miRNA-541 pull-downs, 
respectively. (C) EMSA analysis with pre-miRNA-182 and pre-miRNA-541. Lanes 1 
represent the loading control. Lanes 2 to 5 and 7 to 10 show EMSA with recombinant 
Lin28a (0.5 ng, 5 ng, 50 ng and 100 ng).  
 
Figure 9. (A) Distribution of Lin28a CLIP motifs in loci of upregulated (left panel) 
and downregulated (right panel) miRNAs (miRNAs regulated more than two-fold up 
or down by untagged Lin28a but not regulated by GFP-tagged Lin28a) versus all pri-
miRNAs. rs – represents Spearman Rank-order Coefficient. (B,C) Correlation of 
Lin28a CLIP motifs count between (B) randomized sequence and selected (up and 
downregulated) pri-miRNAs; (C) randomized RNA sequence and all pri-miRNAs. 









